Education
About Us
Working with TipRanks
Follow Us
Brian Daniels Insider Profile
4 Followers
Brian Daniels, SVP Global Dev & Med Affairs at Bristol-Myers Squibb, holds 94.37K shares in Bristol-Myers Squibb (Ticker: BMY), holds ― shares in Cabaletta Bio (Ticker: CABA), holds ― shares in Artiva Biotherapeutics, Inc. (Ticker: ARTV).
Brian Daniels has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Brian Daniels holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 06, 2014 - Feb 06, 2015
Return:-25.20%
The most profitable trade made by Brian Daniels
Brian Daniels's Trading History
Bristol-Myers Squibb
Jul 02, 2014
SVP Global Dev & Med Affairs
Uninformative Buy
101.20K
$4.65M
Cabaletta Bio
―
Director
―
―
Artiva Biotherapeutics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Brian Daniels's performance on stock
You May Also Like
Brian Daniels insider profile FAQ
What is the percentage of profitable transactions made by Brian Daniels?
The percentage of profitable transactions made by Brian Daniels is ―.
What is the average return per transaction made by Brian Daniels?
The average return per transaction made by Brian Daniels is ―.
What stocks does Brian Daniels hold?
Brian Daniels holds: BMY, CABA, ARTV stocks.
What was Brian Daniels’s latest transaction?
Brian Daniels latest transaction was an Uninformative Buy of $101.20K.
What was Brian Daniels's most profitable transaction?
Brian Daniels’s most profitable transaction was an Informative Sell of BMY stock on February 6, 2014. The return on the trade was -25.20%.
What is Brian Daniels's role in Bristol-Myers Squibb?
Brian Daniels's role in Bristol-Myers Squibb is SVP Global Dev & Med Affairs.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.